| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2021) |
Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. |
| 000156 (2021) |
Etienne Meriglier [France] ; Claire Rivoisy [France] ; Mojgan Hessamfar [France] ; Noelle Bernard [France] ; Ines Aureau [France] ; Joelle Lapoirie [France] ; Anne Contis [France] ; Frédéric Sacher [France] ; Benjamin Sacristan [France] ; Marin Lahouati [France] ; Stéphane Pedeboscq [France] ; Marie-Anne Vandenhende [France] ; Stéphane Bouchet [France] ; Fabrice Bonnet [France] | Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection. |
| 000587 (2021) |
Susan Gould [Royaume-Uni] ; Susan L. Norris [États-Unis] | Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19. |
| 000815 (2020) |
Aimé Bonny [Cameroun] ; Mohammed A. Talle [Nigeria] ; Marcus Ngantcha [Cameroun] ; Muzahir H. Tayebjee [Royaume-Uni] | Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000837 (2020) |
Jean Joel Bigna [France] ; Joseph Kamtchum-Tatuene [Canada] ; Jean Jacques Noubiap [Australie] | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence. |
| 000845 (2020) |
Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis] | Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous? |
| 000846 (2020) |
Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France] | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. |
| 000858 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. |
| 000875 (2020) |
Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique] | Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center. |
| 000877 (2020) |
David Lebeaux [France] ; Matthieu Revest [France] | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000990 (2020) |
Bernard La Scola [France] ; Marion Le Bideau [France] ; Julien Andreani [France] ; Van Thuan Hoang [France, Viêt Nam] ; Clio Grimaldier [France] ; Philippe Colson [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. |
| 000A57 (2020) |
Sophie Perinel [France] ; Manon Launay [France] ; Élisabeth Botelho-Nevers [France] ; Éric Diconne [France] ; Aurore Louf-Durier [France] ; Raphaël Lachand [France] ; Martin Murgier [France] ; Dominique Page [France] ; Régine Vermesch [France] ; Guillaume Thierry [France] ; Xavier Delavenne [France] | Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients. |
| 000B47 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 001223 (2020) |
Alice Fanin [Italie] ; Jessica Calegari [Italie] ; Anna Beverina [Italie] ; Silvia Tiraboschi [Italie] | Hydroxychloroquine and azithromycin as a treatment of COVID-19. |
| 001277 (2020) |
Louis Larrouquere [France] ; Manon Gabin [France] ; Emmanuelle Poingt [France] ; Amelle Mouffak [France] ; Alex Hlavaty [France] ; Marion Lepelley [France] ; Charles Khouri [France] ; Alexandre Bellier [France] ; Joachim Alexandre [France] ; Pierrick Bedouch [France] ; Laurent Bertoletti [France] ; Regis Bordet [France] ; Béatrice Bouhanick [France] ; Annie-Pierre Jonville-Bera [France] ; Silvy Laporte [France] ; Claire Le Jeunne [France] ; Louis Letinier [France] ; Joëlle Micallef [France] ; Florian Naudet [France] ; Matthieu Roustit [France] ; Mathieu Molimard [France] ; Vincent Richard [France] ; Jean-Luc Cracowski [France] | Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic. |
| 001545 (2020) |
Peng Liu [France] ; Liwei Zhao [France] ; Gladys Ferrere [France] ; Carolina Alves-Costa-Silva [France] ; Pierre Ly [France] ; Qi Wu [France] ; Ai-Ling Tian [France] ; Lisa Derosa [France] ; Laurence Zitvogel [France] ; Oliver Kepp [France] ; Guido Kroemer [France, République populaire de Chine, Suède] | Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. |
| 001778 (2020) |
François Bénézit ; Audrey Le Bot ; Stéphane Jouneau ; Florian Lemaître ; Charlotte Pronier ; Pierre-Axel Lentz ; Solène Patrat-Delon ; Matthieu Revest ; Vincent Thibault ; Pierre Tattevin | COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020. |
| 001912 (2020) |
Katheron Intson [Canada] ; Sachin Kumar [Canada] ; Amy Botta [Canada] ; Rachael Neckles [États-Unis] ; Connie Leung [Canada] ; Ali Jawaid [Pologne] | An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19. |
| 001A63 (2020) |
Jean-Yves Nau | |
